Targeting Viral Hepatitis: A Road Map for Providers

Medscape Education, in partnership with HealthHIV and HealthHCV, is pleased to announce the release of an education curriculum featuring expert perspectives on the prevention and management of viral hepatitis.

Activities in the Series

  • Driving Hepatitis B Management: Universal Screening and Vaccination in Primary Care
  • Hepatitis C Virus Disparities: Strategies for Bridging the Gap
  • What Is the Priority? Screening, Treatment, and Vaccination Guidelines for Hepatitis B and Hepatitis C

Audiences

This educational curriculum is intended for a US audience of infectious disease specialists, primary care physicians, obstetrician/gynecologists, nurses, nurse practitioners, and physician’s assistants.

Continuing Education

Up to 1.75 continuing education credits (CME / ABIM MOC / CE) are available upon completion of these activities. This curriculum is available free of charge.

Access this curriculum at https://www.medscape.org/collection/viral-hep-cdc-healthhiv

     
HealthHCV’s Fourth Annual State of HCV Care National Survey™

HealthHCV’s Fourth Annual State of HCV Care National Survey evaluates the latest impacts on HCV screening, treatment, and related support services.

     
HealthHCV’s Third Annual State of HCV Care National Survey™

HealthHCV’s Third Annual State of HCV Care National Survey evaluates the latest impacts on HCV screening, treatment, and related support services.

     
HCV 20×20 Resource Guide for Increasing HCV Screening and Linkage to Care

Learn more about model practices for increasing HCV screening and linkage to care in a variety of practice settings.

     
HCV Universal Screening Guidelines Webinar

This recording of a presentation by CDC’s Dr. Sarah Schillie explores CDC’s newest HCV screening recommendations.

     
Opioids and Hepatitis C

This presentation from the SYNChronicity conference examines the effects of Opioid use on HCV.

     
The Circle Model Program

Presented at the SYNChronicity Conference, developed by the Hepatitis C Mentoring and Support Group (HCMSG).

     
Buprenorphine Implementation for Opioid Use Disorder Treatment

The Implementing Transmucosal Buprenorphine for Treatment of Opioid Use Disorder best practice document was designed to fill information gaps and provide guidance.

     
State and Local Movement Towards Hepatitis Elimination

Presented at the SYNChronicity Conference.

     
HCV Microelimination in San Francisco

This presentation examines the development of a microelimination plan.

     
Navigating HCV Care in the Department of Veterans Affairs

Presented at the SYNChronicity Conference by the Hepatic Innovation Team Collaborative Leadership Team of the Veterans Health Administration.

     
AIDSVu and HepVu: Visualizing HIV and HCV To End The Epidemics

Presented at the SYNChronicity Conference.

     
Implementing Routine HCV Testing Along the United States–Mexico Border

Presented at the SYNChronicity Conference.

     
Universal HCV Birth-Cohort Screening

Lessons Learned in an Urban Federally Qualified Health Center (FQHC) Network.

     
Addressing HCV Treatment Barriers in an FQHC

Presented at the SYNChronicity Conference.

     
HCV Among Men Who Have Sex with Men

Key strategies for overcoming barriers to HCV elimination among the MSM community.

     
Medical Case Management Models for HCV

Whole person care for PWID.

     
HCV Treatment Access for People Who Use Drugs

HCV elimination will require going beyond the walls of the clinic.

     
HCV Workforce Needs

HCV Workforce Shortage Demonstrates an Urgent Need to Expand HCV Treatment into Primary Care to Curb the Epidemic.

     
Hepatitis Awareness Month

HHS’s resource page for Hepatitis Awareness.

     
The State of HCV and Critical Viral Hepatitis Strategies

Presented at the SYNChronicity conference, this plan creates a vision of HCV elimination in the United States.

     
Federal Advocacy Efforts at the Intersection of Viral Hepatitis and the Opioid Crisis

An overview of the current landscape of HCV and strategies for elimination advocacy.